Restless legs syndrome. Other specified extrapyramidal and movement disorders
Conditions
Interventions
Intervention 1: tablet pramipexole 0.18mg nightly 2 hours befor sleep for 8 wks. Intervention 2: tablet vitaminC 250mg nightly 2 hours befor sleep for 8 wks. Intervention 3: placebo
one tablet daily for8wks.
Treatment - Drugs
Placebo
tablet pramipexole 0.18mg nightly 2 hours befor sleep for 8 wks
tablet vitaminC 250mg nightly 2 hours befor sleep for 8 wks
placebo
one tablet daily for8wks
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 79 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:Patients undergoing regular hemodialysis;Patients age older than 18 and younger than80;Patients with restless leg syndrom Exclusion criteria:Unstable patients in terms of vital sign;Suffering from an acute illness;History of renal stone;Consuming tricyclic antidepressant, SSRI(selective serotonin reuptake inhibitor),Dopamine antagonist,lithium and sleeping antihistamine .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of symptoms. Timepoint: before and 8weeks after intervention. Method of measurement: Standard questionnaires. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug advers reaction. Timepoint: 8weeks after of intervention. Method of measurement: 8weeks after of intervention. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Shahram Rafie
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed